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ABSTRACT
Objective: With the spread of COVID-19 in Pakistan, Balochistan province with its unique problems of lowest literacy rates in
the country, limited resources and a flail health care system is reporting an increasing number of cases of COVID-19. This study
discusses the epidemiological and clinical characteristics of COVID-19 patients from the Balochistan province.
Study Design: Situation report
Place and Duration of Study: The study was conducted in Balochistan province of Pakistan. The completion date for the
study was April 30, 2020.
Methodology: The data was retrieved from the daily situation report from the Health Department, Government of Balochistan.
Descriptive statistics (proportions, mean ± SD) were used for data analysis.
Results: A total of 1136 patients were confirmed to have COVID-19. The highest rate was found in cases with ages >60 years.
About 78% of COVID-19 cases were males and majority of the cases (78.56%)were asymptomatic. Out of these, 183 recovered
and 16 died. The case fatality rate was 1.3%.
Conclusion: COVID-19 cases and case fatality ratio is low in Balochistan. Whether this is due to inability to carry out more tests
is  still  to  be  ascertained.  Males  and  elderly  are  more  affected  and  fatalities  were  higher  in  cases  with  co-morbid  conditions.
Balochistan having a weak healthcare system and with the majority of cases being asymptomatic, needs more stringent actions
to practice social distancing to avoid further spread of COVID-19.
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INTRODUCTION
A cluster of pneumonia cases of unknown origin were reported
in Wuhan, the capital city of Hubei province, China in December
2019.1
The causative agent of this pneumonia, a novel corona virus,
was isolated after a few days and sequenced, which revealed
resemblance to corona viruses such as SARS-CoV-14 and MERS--
CoV-6 and was labeled SARS-CoV-2 in January 2020. 2 A disease
caused by SARS-CoV-2 was named corona virus disease 2019 
(COVI-19) which has spread to 216 countries, infecting a total of
3,090,445 persons and causing outbreak associated with a new
coronavirus of probable bat origin.2,3
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The disease has attributed to 4,287,961 cases worldwide and
the death toll globally due to COVID-19 is 288,318, as of May 12,
2020.4 COVID-19 can cause mild flu-like symptoms, including
fever, cough, dyspnea, myalgia, and fatigue, while the serious
form  of  COVID-19  can  cause  acute  respiratory  distress
syndrome (ARDS), severe pneumonia, septic shock, and organ
failure and can lead to death.2,3
The World Health Organization (WHO) announced that COVID-19
should be characterized as a pandemic on March 11, 2020.4,5 The
total number of deaths associated with COVID-19 in Italy, Spain,
France, and the United States has exceeded that in China.5
In Pakistan, the confirmed number of cases as of May 12, 2020
was 32,674 and the death toll reached to 724 cases, with a case
fatality rate of 2.2%.4,5 The first case of COVID-19 in Pakistan
was confirmed on 26 February, 2020 by the Ministry of Health,
Government of Pakistan, in a person who had just returned from
Iran.6 The disease spread to Iran, the neighboring country of
Pakistan, from where it had spread quickly to Pakistan owing to
the thousands of pilgrims who entered from Iran to Pakistan via
Balochistan province.
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Balochistan received 3000 pilgrims from Iran and kept them in
quarantine center at Taftan in the first week of March, 2020; the
numbers later exceeded 6000. The first case of COVID-19 in
Balochistan was reported on March 10, 2020.7As of the current
situation, the number of confirmed cases in Balochistan is 2061
(May 12, 2020), while the death toll is 27.8
Pakistan is a middle to low income country with a weak health
care delivery system. However, the response by the Pakistan
government has been commendable to the global COVID-19
crisis. Balochistan could have been at the center of the coron-
avirus outbreak as a result of the quarantine crisis at Taftan.
However, the Government of Balochistan took a timely decision
and started screening of all people crossing the borders, estab-
lishing quarantine centers, followed by closure of all  educa-
tional institutes and later a lockdown in the province.
The objective of this study was to find out the characteristics of
patients  presenting  with  COVID-19 in  Balochistan,  including
brief comment on the epidemiology and clinical features. This
study also discusses emerging COVID-19 pandemic based on
the current evidence.
METHODOLOGY
Situated in southwest of Pakistan, Balochistan province borders
Afghanistan and Iran in the west and the Arabian Sea in the
south. It accounts for nearly half of Pakistan's land mass and is
immensely rich in natural resources, including oil, gas, coal,
copper and gold. According to 2017 census data, the population
of  Balochistan  is  12.34  million  with  6,483,653  males  and
5,860,646 females.9
The study was designed as a situation report. The data was
retrieved from the official daily situation report from the Health
Department of Government of Balochistan. The data consisted
of 9821 subjects who were suspected of having COVID-19 based
on  their  history  of  travel,  exposure  to  a  persons  having
COVID-19,  or  having any of  the symptoms of  COVID-19,i.e.,
fever,  cough,  sore  throat  or  shortness  of  breath.  The  data
included  subjects  from  all  districts  of  Balochistan.  Nasal  or
throat swab for COVID-19 PCR tests were conducted for confir-
mation of having COVID-19. The completion date for the study
was April 30, 2020.
A written permission was taken from the Health Department of
Balochistan for use of the data for this study.
Statistical analysis was carried out using SPSS software (Statis-
tical Package for the Social Sciences, version 19). Mean and
standard deviation was reported for age and proportions were
calculated for all other indicators. Case positivity rate was calcu-
lated by dividing confirmed COVID cases by number of tests
conducted. Age-specific COVID-19 cases and attack rate was
reported. Attack rate was calculated by dividing the number of
COVID-19 cases in the specific age group by number of popula-
tion in the specific age group per 1,000,000 population.  Case
fatality rate (CFR) was calculated by dividing number of deaths
by COVID-19 with number of diagnosed COVID-19 cases.
RESULTS
Screening of 26,220 people was done in Balochistan by the
health  department.  For  the  15,335  suspected  cases,  9,821
tests were conducted for confirmation of COVID-19. A total of
1,136 patients were confirmed to have COVID-19, while 8,685
people tested negative for the disease. The COVID-19 positivity
rate was 11.56%. From the above 1,136 patients, 183 patients
recovered and 16 died of COVID-19 in Balochistan. The active
cases from Balochistan were 937 (Figure 1).
Figure 1: COVID-19 Case Details in Balochistan (April 30th, 2020).
Figure 2: Gender Based Distribution of COVID-19 Cases in Balochistan.
The majority, 770 (93.2%), of the cases were from Quetta, the
capital city of Balochistan province, followed by small percent-
ages from other districts surrounding Quetta.
 District wise, the attack rate/1,000,000 population was highest in
Quetta (353) too, followed by Pishin (64), Sibi  (62) and Khuzdar
(60).
In Quetta city, the highest attacke rate was reported in the union
council  Marriabad (UC 6,7) where most people travelling to Iran
resided.
The mean age of the cases was 35 years, with the age range of
minimum of 2 months to maximum of 94 years. The most affected
age group was 30-44 years (n=353:33.84%) followed by 15-29
years (n=277:26.07%). The highest attack rate (278/1,000,000
population) was reported in the age group 60+ years, followed by
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45-59 years age group (205/1,000,000 population). The overall
attack rate was 74/1,000,000 population in the Province (Table I).










years 93 8.90% 6715115 14
15-29
years 277 26.51% 2832969 98
30-44
years 353 33.78% 2462510 143
45-59
years 195 18.66% 884338 221
60 or more 84 8.04% 295446 284
Unknown 43 4.11%   
Total 1045 100% 13190378 79
^Population of Districts are taken from 2017 censes and population of
year 2020 was calculated with growth rate of 2.6.
Table II: Clinical pattern of disease of COVID-19 patients in Balochistan.




Runny nose 29 2.78%
Body ache 69 6.60%
Head ache 43 4.11%
Sore throat 36 3.44%
Rigors 2 0.19%
Shortness of breath 31 2.97%
No Information on symptoms 57 5.45%
$
Individual symptoms sum cannot be 100%
It was reported that 78% (n=817) of patients with COVID-19 were
males while 22% (n=228) were females (Figure 2).
Of the cases found to be positive, 13.78% (n=144) had a history of
international  travel  while  local  transmission  accounted  for
86.22% (n=901).
Majority  of  the patients (78.56%)who were tested positive for
COVID-19  were  reported  to  be  asymptomatic.  Approximately,
13.30% presented with fever,  10.14% with cough,  6.60% had
body  aches,  and  3.44%  sore  throat.Shortness  of  breath  was
reported to be among 2.97%.2.7% had runny nose.Rigors were
present in 0.19%and 5.45% of  the patients didnot have any infor-
mation of symptoms (Table  II).
The  mean  duration  of  hospitalizationor  test  negativitywas
recorded as 19 days with a range of7 to 27 days.
The total number of people who died of COVID-19 in the province
were  16,  mostly  due  to  co-morbid  conditions  associated  with
COVID-19. The fatalities reported from COVID-19 were associated
with; hypertension and diabetes (n=6), ARDS/COPD (n=4), renal
failure (n=3), and carcinoma (n=1). The CFR was calculated to be
1.3% in Balochistan. The recovery rate of positive cases was 16 %
(n=183).
DISCUSSION
COVID-19 has rapidly spread all across Pakistan. Balochistan
province, has reported fewer cases compared to other densely
populated provinces of Pakistan.
One factor could be the lower testing capacity of Balochistan
compared to other provinces of Pakistan.10 The authors are of
the view that the total number of COVID-19 cases is likely to be
higher but under reported due to the difficulties in identifying
and reporting of mild and asymptomatic cases present in the
community.
The positivity rate was reported to be 11.59% in Balochistan
province, which is higher than that reported in some countries
like India and South Korea (2.6% and 2.7%, respectively) but
lower than countries  like Italy (19.8% as of 20thMarch, 2020) 
and Spain etc.11,12  South Korea has adopted the approach of
doing community testing, thus yielding lower positivity rates.I-
taly, on the other hand, carried out testing on the symptomatic
and severe cases, which might have resulted in a higher posi-
tivity rate.
While  the  main  affected  group  was  the  younger  age  group
(30-44 years), the attack rate was reported to be highest in the
elderly (60+ year group). This could be worrying as interna-
tional studies have shown poor clinical outcomes associated
with older age and underlying co-morbidities.13
Comparable to international studies, females and children were
less affected by COVID-19 in Balochistan.14 This could be due to
the fact that in some provinces of Pakistan, males are the sole
bread earners and usually go out of homes for work. The reports
from China and Italy indicate that  females and children are
underrepresented,  especially  among  severe  and  fatal
cases.15,16 It is still not known whether this is because of less expo-
sure, or because they are less likely to show symptoms or are
less likely to get infected.
In contrast to previous studies, the majority of patients with
COVID-19 in Balochistan were asymptomatic.17,18 This could be
problematic,  as  the  asymptomatic  patients  will  continue  to
infect  more  people  without  being  detected.  Another  study
conducted in Iceland reported that 43% of the participants who
tested positive reported no symptoms.19
The CFR reported in Balochistan is lower than many countries.
Italy has a CFR of 13.59, Spain 11.40, Germany 3.9, India 3.2,
and Iran 6.3, (as of 30th April, 2020). Singapore, on the other
hand, had a CFR of 0.09.5The recovery rate of positive cases in
the province was 16%.
Many factors can confound the estimation for CFR and recovery
rate, such as, undetected cases or delayed case reporting can
significantly affect the CFR and recovery rate and thus it has to
be interpreted with caution. More research is needed to ascer-
tain into these factors.
Mortality fromCOVID-19 was associated with co-morbids like
hypertension and diabetes in Balochistan. International data
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also show mortality in COVID-19 to be higher in patients with
underlying health conditions.14, 18
Government  of  Balochistan  has  adopted  unprecedented
measures to limit the spread of the virus and flatten the curve.
These measures include starting screening process, establish-
ment of quarantine centers, closing borders with neighboring
countries,  closing  educational  institutions,  imposing  ban  on
public gatherings and implementing province-wise lockdowns.
However, since the report shows the transmission to be local
and the cases to be asymptomatic in the area, if strict social
distancing is not practiced, the numbers could rise exponen-
tially and the healthcare system will not be able to effectively
handle the burden.
Due to the shortage of COVID-19 testing kits, we recommend
that  the  criteria  of  clinically  diagnosed  cases  based  on  the
history of exposure, clinical symptoms and typical X-ray chest
(CT chest imaging if available) should be used to detect, isolate
and monitor suspected cases, thus limiting the spread, while
reserving the healthcare facilities for the more severe cases.
It  is strongly recommended that medical supplies, including
personal protective equipments (PPEs), should be provided to
hospitals  at  district  level  to  aid  the  healthcare  providers  in
dealing  with  the  ever  increasing  cases  of  the  COVID-19
pandemic. Besides this, invasive equipment including ventila-
tors  should be provided to divisional  headquarter  hospitals/
teaching hospitals of the medical colleges, so that the coming
burden of severe cases can be decreased on the tertiary care
hospital of the main cities.
COVID-19 has posed huge challenges to countries with inade-
quate healthcare infrastructures and lack of preparedness to
deal  with  such pandemic.  Weak infrastructure  and financial
constraints in Pakistan are the major factors hindering response
to  the  current  pandemic.  So,  the  government  should  make
liaison with private sectors to invest in public health interven-
tions.
Stringent  policies  for  the  implementation  of  public  health
measures should be taken to prevent transmission of COVID-19
including wearing mask, hand washing and social distancing,
etc.
Researches should be carried out to assist the government in
shaping up COVID-19 policies.
Though the National, Provincial and District Disaster Manage-
ment Authorities and the key players at the federal and provin-
cial levels are working meticulously to address the pandemic
issue but international communities must come forward to help
the third world countries like Pakistan to help them come out of
this pandemic.
CONCLUSION
COVID-19 pandemic has challenged the healthcare system of
every  country  and  Pakistan  being  a  low  to  middle-income
country,  is  facing  a  massive  task  in  addressing  this  issue.
Currently, the virus has not yet been contained and the most
terrifying  situation  may  arise  with  the  surge  of  seriously  ill
patients requiring intensive care and ventilators.  However, on
a positive side, this pandemic has given us the opportunity to
indeed strengthen our healthcare delivery system. Multi-sec-
toral interventions are required to address this public health
emergency.
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